Tag: clinical trials
-
Text Messages Help Young Adults Reduce Binge Drinking
11 July 2014. Medical researchers at University of Pittsburgh show mobile phone text messages can provide feedback to young adults with a history of alcohol abuse that cuts their binge drinking. Findings from the team led by emergency medicine professor Brian Suffoletto were published online earlier this week in the journal Annals of Emergency Medicine.…
-
Dengue Vaccine Shown to Cut Infections, Hospitalizations
11 July 2014. A large-scale clinical trial of a vaccine by the pharmaceutical company Sanofi shows the vaccine prevents symptomatic dengue cases by more than half, with severe forms and hospitalizations from the disease reduced even further. Findings from the study, conducted among more than 10,000 children in five Asian countries, are reported online today…
-
Baxter Acquires Sickle-Cell Prevention Drug Developer
10 July 2014. Baxter International in Deerfield, Illinois is acquiring AesRx LLC, a biopharmaceutical company in Newton, Massachusetts developing drugs for sickle-cell and other rare diseases. Baxter is making an initial payment to AesRx, which will be eligible for future payments tied to development and commercial milestones, but dollar amounts were not disclosed. Sickle cell…
-
Personal Leukemia Immunotherapy Given Breakthrough Status
7 July 2014. The U.S. Food and Drug Administration designated as a breakthrough a personalized immunotherapy developed by University of Pennsylvania in Philadelphia to treat acute lymphoblastic leukemia that does not respond to other treatments or has relapsed. FDA assigns a breakthrough designation and accelerates review of drugs or biologic therapies that treat a serious…
-
Trial: Insulin Pumps Better Control Glucose Than Injections
3 July 2014. An international clinical trial shows insulin pumps worn by people with type 2 diabetes do a better job of controlling blood glucose levels than multiple daily injections of insulin, the usual control treatment. Results from the post-marketing study funded by Medtronic Inc., a medical device developer in Minneapolis that makes insulin pumps,…
-
Online Clinical Trial with Children Tests Autism Therapy
30 June 2014. Researchers at University of California in San Francisco and Kennedy Krieger Institute in Baltimore completed a clinical trial conducted entirely online testing the ability of omega-3 fatty acids to control hyperactivity in children with autism. The team led by UC-San Francisco medical professor Stephen Bent published its findings in this month’s issue…
-
FDA Approves Motorized Exoskeleton for Spinal Cord Injury
27 June 2014. The Food and Drug Administration yesterday cleared for sale in the U.S. a motorized exoskeleton system for people with lower-body paralysis from spinal cord injury. The device, called ReWalk, is made by Argo Medical Technologies in Marlborough, Massachusetts, and according to FDA, the first system of its kind approved to help people…
-
Late Trial Testing Topical Gel for Diabetic Nerve Pain
26 June 2014. A late-stage clinical trial testing a topical gel to treat diabetic nerve pain completed its enrollment, according to BioDelivery Sciences International in Raleigh, North Carolina, the study’s sponsor. The trial is the first of two clinical studies of Clonidine Topical Gel in preparation for the company’s new drug application with the U.S.…
-
Early Trial Shows Neural Regrowth Effects on Depression
25 June 2014. An early-stage clinical trial by Neuralstem Inc. in Germantown, Maryland provides evidence its experimental drug to treat major depressive disorder is having a positive impact on patients’ brain activity and behavior. The company reported the findings yesterday at a meeting of the International College of Neuropsychopharmacology in Vancouver, Canada, and last week…
-
Paralyzed Man Moves Hand with Neuro-Signal Implant System
24 June 2014. Engineers at Battelle Memorial Institute and physicians at Ohio State University medical center in Columbus demonstrated a device that enables people with a spinal cord injury to direct movement of limbs with their thoughts. The research team’s first patient is Ian Burkhart, a 23 year-old man from Dublin, Ohio taking part in…